2922281-15-8
Chemical Structure
Coronastat
Synonym(s): NK01-63
- CAS No.: 2922281-15-8
- Formula:C22H29F3N3NaO8S
- Molecular Weight:575.53
IUPAC Name: sodium (2S)-1-hydroxy-2-((S)-4-methyl-2-((((3-(trifluoromethyl)benzyl)oxy)carbonyl)amino)pentanamido)-3-((S)-2-oxopyrrolidin-3-yl)propane-1-sulfonate
InChIKey: KOKDRBNCVDMTCL-OPOLGWMESA-M
SMILES: OC(S(=O)(O[Na])=O)[C@H](C[C@@H]1CCNC1=O)NC([C@H](CC(C)C)NC(OCC2=CC(C(F)(F)F)=CC=C2)=O)=O
Biological Activity: Coronastat is a potent inhibitor of the SARS-CoV-2 3CL protease. The SARS-CoV-2 3CL protease is a critical agent target for small molecule COVID-19, given its likely agentgability and essentiality in the viral maturation and replication cycle[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Coronastat | 98.0% | Coronastat is a potent inhibitor of the SARS-CoV-2 3CL protease. The SARS-CoV-2 3CL protease is a critical agent target for small molecule COVID-19, given its likely agentgability and essentiality in the viral maturation and replication cycle. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GC376 sodium | 99.53% | GC376 sodium is a 3CLpro inhibitor; inhibits the replication of viruses TGEV, FIPV and PTV with IC50 values of 0.15, 0.2 and 0.15 μM, respectively. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SARS-CoV-2-IN-11 | SARS-CoV-2-IN-11 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.17 and 1.45 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olgotrelvir | Olgotrelvir (STI-1558) is an orally active dual inhibitor of coronavirus main protease (Mpro) and human cell cathepsin (Cathepsin L). Olgotrelvir is readily converted to its active form, AC1115, in full blood and/or plasma. Olgotrelvir can effectively inhibit both SARS-CoV-2 replication and entry into host cells. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Olgotrelvir sodium | 95.0% | Olgotrelvir (STI-1558) sodium is an orally active dual inhibitor of coronavirus main protease (Mpro) and human cell cathepsin (Cathepsin L). Olgotrelvir sodium is readily converted to its active form, AC1115, in full blood and/or plasma. Olgotrelvir sodium can effectively inhibit both SARS-CoV-2 replication and entry into host cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mpro ligand 2 | Mpro ligand 2 (Compound 8) is the ligand for target protein, which can be used for synthesis of PROTAC SARS-CoV-2 Mpro degrader-3 (HY-161789). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MERS-CoV-IN-2 | MERS-CoV-IN-2 (compound 3c) is a MERS-CoV 3CLpro inhibitor (IC50=17nM). MERS-CoV-IN-2 inhibits the activity of the 3CLpro enzyme by binding to the active site of the enzyme, specifically the S4 subsite, thereby exhibiting antiviral activity against SARS-CoV-2 and MERS-CoV. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
UAWJ246 | UAWJ246 is a covalent reversible inhibitor of the SARS-CoV-2 main protease (Mpro), with an IC50 of 0.045 μM and a Ki of 0.036 μM. UAWJ246 exhibits potent antiviral activity by inhibiting SARS-CoV-2 viral replication and shows low cytotoxicity. UAWJ246 can be used in research related to SARS-CoV-2 infection, such as studies on COVID-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
UAWJ-247 | UAWJ-247 is a potent and reversible SARS-CoV-2 main protease (Mpro) inhibitor with an IC50 of 0.042 μM and a Ki of 0.035 μM. UAWJ-247 can be used for the research of covid-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
MPI3 | MPI3 is a reversible covalent SARS-CoV-2 MPro inhibitor with an enzymatic IC50 of 8.5 nM. MPI3 can be used for the research of covid-19. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
GC813 | GC813 is a MERS-CoV 3CL protease (3CLpro) and MERS-CoV main protease (Mpro) inhibitor. GC813 can be used for the research of middle east respiratory syndrome. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||